| 摘要 |
<p>Remedies for diseases in association with a decrease in bone mass which contain EP4 agonists as the active ingredient. Because of having an effect of promoting osteogenesis, EP4 agonists typified by compounds having the prostaglandin skeleton are useful in treating and/or preventing diseases in association with a decrease in bone mass.</p> |
